(Date:11/24/2009)...,Iceland,November24/PRNewswire-FirstCall/--deCODE,...valofallofits,"firstday"motionsbytheU.S.Bankruptcy...").deCODElastweekfiledavoluntarypetitionfor,relief...he,BankruptcyCourt. , TheordersissuedbytheBan...businessduringtheChapter11proceedings.Inparticular...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedt...sapprovedthe,investigationalnewdrugapplication(IND...ulinformulationtotreatdiabetes.ThisIND,approvalall...,, Diabetesisadisordercharacteristicofhighblood...esoftenresultinseveremicro-and,macro-vasculardisea...
(Date:11/24/2009)...ficacyendpointhasbeenmetforpatientswithadvanced-st...Y,Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc....armaceuticalcompanyfocusedonendocrinetherapyandonc...2studywithitstargetedcytotoxicpeptideconjugate,AEZ...rrentendometrialcancer.Inapersonalizedhealthcareap...
(Date:11/24/2009)...Nov.24,2009/PRNewswire-FirstCall/--ArenaPharmaceut...mpanyisscheduledtopresentatthePiperJaffray21stAnnu...asternTime(8:30a.m.PacificTime)attheNewYorkPalaceH...iefExecutiveOfficer,isscheduledtoprovideanoverview...coveryprograms. ,, Aliveaudiowebcastofthepresen...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2...f Operations Outside the US In ...Nov. 6 Northwest,Biotherapeutics, Inc. (OTC Bulle...ced that it has obtained US$1.65 million in fundin... (the "Notes") with SDS Capital Group SPC,Ltd ("SD... Investors"). A,significant portion of the proceed...
...ing Process Documentation for Customer ...., Nov. 5 BioLife Solutions Inc.,(OTC Bulletin Bo...oprietary,hypothermic storage and cryopreservation...ay announced that it has submitted a Master File t...FDA) for the Company,s,HypoThermosol preservation ...
...Technologies, Inc.,a provider of innovative microd...e research, today announced that it has shipped it...application to The Genome Center (GC) at,the Washi...a world leader,in genomics research., Under RainD...l provide,its new RDT 1000 and expert training to ...
Other Biology Technology:Northwest Secures US$1.65 Million Debt Financing 2Northwest Secures US$1.65 Million Debt Financing 3Northwest Secures US$1.65 Million Debt Financing 4BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues 2BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues 3RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis 2Rat Anti-Mouse OSMR Monoclonal Antibody, Unconjugated, Clone 30-1 from MBL International
Mouse Anti-ROCK-1 (cleaved) Monoclonal Antibody, Unconjugated from BioVision
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
mCD-1 Multi-Probe Template Set from BD Biosciences Pharmingen
Biology Products: